These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11817320)

  • 1. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane.
    Ronco C; Bowry S
    Int J Artif Organs; 2001 Oct; 24(10):726-35. PubMed ID: 11817320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface topography and surface elemental composition analysis of Helixone, a new high-flux polysulfone dialysis membrane.
    Bowry SK; Ronco C
    Int J Artif Organs; 2001 Nov; 24(11):757-64. PubMed ID: 11797845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
    Wizemann V; Lotz C; Techert F; Uthoff S
    Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane requirements for high-flux and convective therapies.
    Bowry SK
    Contrib Nephrol; 2011; 175():57-68. PubMed ID: 22188688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence on haemodiafiltration.
    Blankestijn PJ; Grooteman MP; Nube MJ; Bots ML
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii53-iii58. PubMed ID: 30281128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells.
    Bonomini M; Ballone E; Di Stante S; Bucciarelli T; Dottori S; Arduini A; Urbani A; Sirolli V
    Nephrol Dial Transplant; 2004 Jan; 19(1):68-74. PubMed ID: 14671041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'.
    Cuoghi A; Caiazzo M; Monari E; Bellei E; Bergamini S; Sereni L; Aucella F; Loschiavo C; Atti M; Tomasi A
    J Biomater Appl; 2015 May; 29(10):1363-71. PubMed ID: 25542733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis membranes today.
    Bowry SK
    Int J Artif Organs; 2002 May; 25(5):447-60. PubMed ID: 12074344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome for haemodialysis patients treated with high-flux membranes.
    Woods HF; Nandakumar M
    Nephrol Dial Transplant; 2000; 15 Suppl 1():36-42. PubMed ID: 10737165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis. Reference methodology and clinical results. (Part. 2: in vivo study).
    Ronco C; Brendolan A; Cappelli G; Ballestri M; Inguaggiato P; Fortunato L; Milan M; Pietribiasi G; La Greca G
    Int J Artif Organs; 1999 Sep; 22(9):616-24. PubMed ID: 10532430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
    Schiffl H
    Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities.
    Meert N; Eloot S; Schepers E; Lemke HD; Dhondt A; Glorieux G; Van Landschoot M; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2011 Aug; 26(8):2624-30. PubMed ID: 21310741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.